Wednesday, June 10, 2026
🇺🇸 FDA

pharma

Bayer

Bayer patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website
WATERFALL CITY MIDRAND, ZA HQ
1863 Founded
NMPA registrant Type
Company details
Status
Public
HQ
WATERFALL CITY MIDRAND, ZA
Founded
1863
Programs
0
Drugs
0
Patents
25
Official website ↗ Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Bayer patents

25 pharmaceutical patents indexed for Bayer. 0 expire within 24 months.

Bayer has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

25 patents

Patent portfolio

  1. WO 2026112109

    TECHNOLOGIE DE PLATEFORME DE GRANULATION PAR VOIE HUMIDE POUR FABRIQUER DES COMPRIMÉS/ARTICLES À MÂCHER MOUS

    Expires Wed May 23 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026106858

    FORMULATIONS ET PROCÉDÉS POUR MAINTENIR UNE SUSPENSION ET UNE VIABILITÉ DE CELLULES

    Expires Wed May 16 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. EP 4741400

    MULTIMERE MANGANKONTRASTMITTEL

    Expires Tue May 08 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2026068294

    PROCESSUS DE NANOENSEMENCEMENT AMÉLIORÉ

    Expires Wed Mar 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. WO 2026047022

    FORME POSOLOGIQUE PHARMACEUTIQUE SOLIDE ET STABLE COMPRENANT UNE FORME CRISTALLINE D'UN INHIBITEUR DE HER2/MUTEGFR ET SA MÉTHODE DE PRÉPARATION

    Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2026047020

    FORMES CRISTALLINES D'INHIBITEURS DE HER2/MUTEGFR ET LEUR PROCÉDÉ DE PRÉPARATION

    Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 20260051027

    GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES

    Expires Wed Feb 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2026032865

    SEL D'UN INHIBITEUR DE SOS-1

    Expires Wed Feb 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. EP 4691463

    VERFAHREN ZUR PRÄVENTION ODER BEHANDLUNG VON HERZVERSAGEN BEI EINEM PATIENTEN MIT (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXAMID

    Expires Tue Feb 06 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2026027375

    HYDROXY-DIHYDROPYRIDINON CARBOXAMIDE ALS SCHÄDLINGSBEKÄMPFUNGSMITTEL

    Expires Wed Jan 31 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12533358

    Methods of treatment with elinzanetant

    Expires Mon Jan 22 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2026015433

    PRÉPARATION IN SITU DE COMPOSITIONS GOMMEUSES EN BLISTER

    Expires Wed Jan 10 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2026015429

    BONBONS GOMMEUX À COMPRESSION DIRECTE

    Expires Wed Jan 10 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. WO 2026008525

    FORMULATIONS STABLES CONTENANT DES RADIONUCLÉIDES

    Expires Wed Jan 03 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. WO 2026006232

    COMPOSITION EFFERVESCENTE ORALE

    Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2025256977

    NOUVELLES ENZYMES DE CLIVAGE IGM ET IGG

    Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2025247981

    DOSAGE PHARMACEUTIQUE DÉRIVÉ DE FUROINDAZOLE

    Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. WO 2025247801

    DÉTERMINATION D'UN DOSAGE D'UN ANTAGONISTE DU RÉCEPTEUR MINÉRALOCORTICOÏDE NON STÉROÏDIEN

    Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. WO 2025242584

    FORMULATION DE CAPSULE DE GÉLATINE MOLLE STABLE POUR ÉLINZANÉTANT

    Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2025242585

    FORMES CRISTALLINES DE SELS D'ÉLINZANÉTANT ET COMPOSITIONS CONTENANT DES SELS D'ÉLINZANÉTANT

    Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. WO 2025242583

    NOUVELLE FORMULATION COMPRENANT DE L'ÉLINZANÉTANT DANS UNE DISPERSION SOLIDE

    Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. WO 2025224069

    CO-CRISTAUX DE FINÉRÉNONE, DE PECAVAPTAN ET D'INHIBITEURS DE SGLT2

    Expires Wed Oct 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2025219169

    PRÉPARATIONS STABLES EN CAPSULES SOUPLES AVEC REMPLISSAGE LIQUIDE POUR PRINCIPES ACTIFS SENSIBLES À L'HUMIDITÉ

    Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. WO 2025202022

    INHIBITEURS DE L'INTERACTION ENTRE RAS ET SOS1 À BASE DE QUINAZOLINE, MACROCYCLIQUES ET ANTICANCÉREUX

    Expires Wed Sep 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. WO 2025186043

    FORMULATION PHARMACEUTIQUE POUR ANTICORPS ANTI-CCR8

    Expires Thu Sep 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Bayer have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Bayer patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.